Said M. Afify
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
- Oncology 34
- Cancer Cells and Metastasis 34
-
- Pluripotent Stem Cells Research 17
- Epigenetics and DNA Methylation 6
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- Masaharu Seno (39 shared papers)Ghmkin Hassan (32 shared papers)Akimasa Seno (33 shared papers)Maram H. Zahra (26 shared papers)Xiaoying Fu (9 shared papers)Amira Osman (8 shared papers)Md. Jahangir Alam (7 shared papers)Juan Du (6 shared papers)
In The Last Decade
Said M. Afify
39 papers receiving 723 citations
Peers
Comparison fields: 5 of 86
- Oncology 364
- Cancer Research 165
- Molecular Biology 438
- Immunology 91
- Genetics 42
Countries citing papers authored by Said M. Afify
This map shows the geographic impact of Said M. Afify's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Said M. Afify with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Said M. Afify more than expected).
Fields of papers citing papers by Said M. Afify
This network shows the impact of papers produced by Said M. Afify. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Said M. Afify. The network helps show where Said M. Afify may publish in the future.
Co-authors
The 25 scholars most cited alongside Said M. Afify, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 135 | |
| 2 | 2022 | 71 | |
| 3 | 2021 | 63 | |
| 4 | 2020 | 47 | |
| 5 | 2020 | 45 | |
| 6 | 2019 | 36 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 22 | |
| 9 | 2019 | 19 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 18 | |
| 12 | 2020 | 16 | |
| 13 | 2022 | 14 | |
| 14 | Isolation and characterization of cancer stem cells derived from human glioblastoma. | 2021 | 14 |
| 15 | 2020 | 14 | |
| 16 | 2018 | 13 | |
| 17 | 2021 | 13 | |
| 18 | 2021 | 13 | |
| 19 | 2020 | 11 | |
| 20 | 2020 | 11 |
About Said M. Afify
Said M. Afify is a scholar working on Oncology, Molecular Biology, Biomedical Engineering, Cancer Research and Cell Biology, having authored 40 papers that have together received 730 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (34 papers), Pluripotent Stem Cells Research (17 papers), 3D Printing in Biomedical Research (9 papers), Epigenetics and DNA Methylation (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), MicroRNA in disease regulation (3 papers), Cancer Research and Treatments (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). The work is most often cited by research in Oncology (364 citations), Cancer Research (165 citations), Molecular Biology (438 citations), Immunology (91 citations) and Genetics (42 citations). Said M. Afify has collaborated with scholars based in Japan, Egypt and Syria. Frequent co-authors include Masaharu Seno, Ghmkin Hassan, Akimasa Seno, Maram H. Zahra, Xiaoying Fu, Amira Osman, Md. Jahangir Alam, Juan Du, Aung Ko Ko Oo and Anna Sanchez Calle. Their work appears in journals such as Cancers, Scientific Reports, British Journal of Cancer, Advances in experimental medicine and biology and American Journal of Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.